Arcutis Biotherapeutics - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsArcutis Biotherapeutics

Arcutis Biotherapeutics(ARQT)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Quarterly sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Zoryve	Roflumilast	2022-07-29	2023-2037	Chronic obstructive pulmonary disease

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

,

healthy volunteers/patients

,

large b-cell lymphoma diffuse

,

b-cell lymphoma

,

alzheimer disease

,

neuronal plasticity

,

,

memory disorders

,

hematologic neoplasms

,

,

b-cell chronic lymphocytic leukemia

,

,

,

hematopoietic stem cell transplantation

,

cell- and tissue-based therapy

,

adoptive immunotherapy

,

,

lymphocyte transfusion

,

hidradenitis suppurativa

,

,

,

,

non-alcoholic fatty liver disease

,

rheumatoid arthritis

,

,

depressive disorder

,

respiratory distress syndrome

,

acute lung injury

,

newborn respiratory distress syndrome

,

,

,

cognitive dysfunction

,

cognition disorders

,

nervous system diseases

,

polyostotic fibrous dysplasia

,

,

metabolic syndrome

,

cerebrovascular disorders

,

,

recovery of function

,

,

fragile x syndrome

,

peripheral nervous system diseases

,

,

,

,

,

,

type 2 diabetes mellitus

,

seborrheic dermatitis

,

diabetes mellitus

,

major depressive disorder

,

prediabetic state

,

diabetic nephropathies

,

kidney diseases

,

respiratory signs and symptoms

,

diabetic neuropathies

,

,

chronic obstructive pulmonary disease

,

obstructive lung diseases

,

,

,

,

atopic dermatitis

,

,

chronic bronchitis

,

disease progression

,

,

chronic disease

,

,

,

,

,

atherosclerosis

,

respiratory tract diseases

,

respiration disorders

,

ulcerative colitis

,

,

,

alopecia areata

,

,

hypersensitivity

,

idiopathic pulmonary fibrosis

,

pulmonary fibrosis

,

,

cardiovascular diseases

,

,

,

human influenza

healthy volunteers/patients

,

colorectal neoplasms

,

chronic renal insufficiency

,

kidney diseases

,

sickle cell anemia

,

knee osteoarthritis

,

,

,

,

ovarian neoplasms

,

,

ovarian epithelial carcinoma

,

head and neck neoplasms

,

squamous cell carcinoma

,

squamous cell neoplasms

,

laryngeal neoplasms

,

opioid-related disorders

,

,

coronavirus infections

,

,

,

brain neoplasms

,

,

neurofibromatosis 2

,

acoustic neuroma

,

,

,

neurofibromatosis 1

,

neurofibromatoses

,

,

,

,

cystic fibrosis

,

,

soft tissue neoplasms

,

biliary tract neoplasms

,

,

urinary bladder neoplasms

,

invasive hydatidiform mole

,

non-muscle invasive bladder neoplasms

,

non-hodgkin lymphoma

,

b-cell chronic lymphocytic leukemia

,

mantle-cell lymphoma

,

b-cell lymphoma

,

b-cell leukemia

,

diabetes mellitus

,

chronic obstructive pulmonary disease

,

,

non-small-cell lung carcinoma

,

,

pulmonary eosinophilia

,

,

,

,

,

endometrial neoplasms

,

borderline personality disorder

,

personality disorders

,

churg-strauss syndrome

,

eosinophilic granuloma

,

type 2 diabetes mellitus

,

breast neoplasms

,

,

,

,

endomyocardial fibrosis

,

postoperative pain

,

,

major depressive disorder

,

depressive disorder

,

systemic lupus erythematosus

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use